- Home
- RYAN vs CORT Comparison
RYAN vs CORT Comparison
Compare RYAN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYAN
- CORT
- Stock Information
- Founded
- RYAN 2010
- CORT 1998
- Country
- RYAN United States
- CORT United States
- Employees
- RYAN N/A
- CORT N/A
- Industry
- RYAN Specialty Insurers
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- RYAN Finance
- CORT Health Care
- Exchange
- RYAN Nasdaq
- CORT Nasdaq
- Market Cap
- RYAN 8.4B
- CORT 7.1B
- IPO Year
- RYAN 2021
- CORT N/A
- Fundamental
- Price
- RYAN $73.88
- CORT $112.29
- Analyst Decision
- RYAN Buy
- CORT Strong Buy
- Analyst Count
- RYAN 13
- CORT 4
- Target Price
- RYAN $75.27
- CORT $127.00
- AVG Volume (30 Days)
- RYAN 863.7K
- CORT 1.7M
- Earning Date
- RYAN 05-01-2025
- CORT 04-30-2025
- Dividend Yield
- RYAN 0.65%
- CORT N/A
- EPS Growth
- RYAN 37.73
- CORT 30.85
- EPS
- RYAN 0.71
- CORT 1.23
- Revenue
- RYAN $2,455,671,000.00
- CORT $675,040,000.00
- Revenue This Year
- RYAN $27.34
- CORT $36.81
- Revenue Next Year
- RYAN $16.21
- CORT $29.94
- P/E Ratio
- RYAN $103.43
- CORT $92.86
- Revenue Growth
- RYAN 21.17
- CORT 39.94
- 52 Week Low
- RYAN $48.48
- CORT $20.84
- 52 Week High
- RYAN $75.97
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- RYAN 65.65
- CORT 84.76
- Support Level
- RYAN $71.19
- CORT $53.79
- Resistance Level
- RYAN $74.08
- CORT $61.09
- Average True Range (ATR)
- RYAN 1.67
- CORT 3.65
- MACD
- RYAN 0.21
- CORT 3.22
- Stochastic Oscillator
- RYAN 88.93
- CORT 97.96
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.